Enrique Poradosu,James F. Oliviero, III,Ron Bentsur
申请号：
US13924332
公开号：
US20130345303A1
申请日:
2013.06.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Methods of administering ferric citrate to reduce and/or control serum phosphorus levels, increase serum bicarbonate levels, improve one or more iron storage parameters (e.g., increase serum ferritin levels, increase transferrin saturation (TSAT), increase hemoglobin concentration) increase iron absorption, maintain iron stores, treat iron deficiency, treat anemia, reduce the need for IV iron and/or reduce the need for erythropoiesis-stimulating agents (ESAs) in chronic kidney disease patients, are disclosed.
